Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
BeOne Medicines
BeOne Medicines
Thomas Jefferson University
BeOne Medicines
National Institutes of Health Clinical Center (CC)
Nurix Therapeutics, Inc.
Genmab
Calibr, a division of Scripps Research
Genmab
Vironexis Biotherapeutics Inc.
AbbVie
Nurix Therapeutics, Inc.
Cellectar Biosciences, Inc.
MEI Pharma, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Galapagos NV
Masonic Cancer Center, University of Minnesota
BeOne Medicines
University of Chicago
University of Washington
Eli Lilly and Company
Fred Hutchinson Cancer Center
Mayo Clinic
Medical College of Wisconsin
BeOne Medicines
Ascentage Pharma Group Inc.
Newave Pharmaceutical Inc
Schrödinger, Inc.
Mayo Clinic
Eli Lilly and Company
City of Hope Medical Center
BeOne Medicines
iOMEDICO AG
Eli Lilly and Company
Prelude Therapeutics
University of California, San Francisco
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
City of Hope Medical Center
H. Lee Moffitt Cancer Center and Research Institute
Carna Biosciences, Inc.
National Cancer Institute (NCI)
City of Hope Medical Center
BeOne Medicines
Seoul National University Hospital
CRISPR Therapeutics
University of Arizona
Case Comprehensive Cancer Center
University of Washington
Massive Bio, Inc.
UNC Lineberger Comprehensive Cancer Center